¹Assistant Professor, Department of Radiation Oncology, Cama & Albless Hospital, Mumbai, Maharashtra, INDIA.

²Associate Professor, ³Professor, Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, INDIA.

Email: ganeshthakur512@gmail.com

REFERENCES

1. Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu MC, Martin M, Namer M, O’Shaughnessy JA, Shen ZZ, Albain KS: The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 2005, 6: 391-401.
2. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin2005, 55:74-108.
3. Priyashetty: World report, India faces growing breast cancer epidemic. Lancet Vol 379 pp 992-93 (accessed on March 17, 2014).
4. van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl CancerInst Monogr. 1992;(11):15-18. http://www.ncbi.nlm.nih.gov/pubmed/1627421.
5. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N EnglJ Med. 2002;347(16):1227-1232.
6. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-1241. http://www.ncbi.nlm.nih.gov/pubmed/12393820\nhttp://www.nejm.org/doi/pdf/10.1056/NEJ Moa022152.
7. Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-1716.
8. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. NEngl J Med. 1995;333(22):1456-1461.
9. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J ClinOncol. 2006;24(13):2028-2037. doi:10.1200/JCO.2005.04.3273.
10. Dershaw DD, Mccormick B, Osborne MP. Detection of Local Recurrence After ConservativeTherapy for Breast Carcinoma.
11. Parmar V, Krishnamurthy A, Hawaldar R, Nadkarni MS. Breast conservation treatment in women with locally advanced breast cancer e Experience from a single centre. 2006. doi:10.1016/j.ijsu.2006.01.004.
12. Annemeike et al.:Survival after Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval,PLOS ONE, DOI:10.1371/journal.pone.0120832 April 10, 2015
13. Voogd AC, van Tienhoven G, Peterse HL, et al. Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Cancer. 1999;85(2):437-446.
14. Rauschecker H, Clarke M, Gatzemeier W, et al. Systemic therapy for treating locoregional recurrence in women with breast cancer.Cochrane Database Syst Rev(4)., CD002195.